Creo Medical Group Plc (CREO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2018 | 06-2017 | 02-2016 | 02-2015 | |
| Sales | 13 | 0 | 0 | 0 | 0 |
| Cost of Goods | 9 | N/A | N/A | N/A | N/A |
| Gross Profit | 5 | N/A | N/A | N/A | N/A |
| Operating Expenses | 18,880 | 10,285 | 8,903 | 3,802 | 2,881 |
| Operating Income | -18,875 | -10,285 | -8,903 | -3,802 | -2,881 |
| Interest Expense | 23 | 8 | 3 | 3 | 0 |
| Other Income | 283 | 8 | -2 | 7 | 3 |
| Pre-tax Income | -18,615 | -10,285 | -8,908 | -3,798 | -2,878 |
| Income Tax | -2,704 | -1,877 | -1,143 | -468 | -496 |
| Net Income Continuous | -15,911 | -8,409 | -7,766 | -3,330 | -2,382 |
| Net Income | $-15,911 | $-8,409 | $-7,766 | $-3,330 | $-2,382 |
| EPS Basic Total Ops | -0.13 | -0.10 | -0.13 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.13 | -0.10 | -0.13 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.13 | -0.10 | -0.13 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.13 | -0.10 | -0.13 | -0.04 | -0.03 |
| EBITDA(a) | $-17,950 | $-9,837 | $-8,763 | $-3,692 | $-2,804 |